Proteomics and Metabolomics, a part of system biology, is fundamental for a full understanding of a biological system including a metabolic process or disease state, and has received considerable attention since the sequencing of the human genome. Mass spectrometry based technologies have been indispensable to the development of molecular medicine. Clinical research can also benefit from proteomics and metabolomics by both the identification of new drug targets and the development of new diagnostic markers.

Mission

Offer state of the art proteomics and metabolomics service to GRU Cancer Center Investigators
Assist in the analysis of data resulting from investigations into the metabolome or proteome.
Assist in the writing of grants or manuscripts involving proteomics or metabolomics